`

Veloxis Pharmaceuticals, Inc

Biotechnology Research

Specialities :
Pharmaceuticals
Biotechnology
And transplant
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$60.0M
size-icon Size
51 - 200

Frequently Asked Questions About Veloxis Pharmaceuticals, Inc

What does Veloxis pharmaceuticals, inc do?+

Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. We know what transplant means to patients, and were leading innovation to improve their experience. For patients, transplant is a life-changing procedure. But changes come with challenges. At Veloxis, our mission is to see and respond to the challenges along the transplant journey. Read our Community Guidelines: https://bit.ly/3FQr7Wg

What are Veloxis pharmaceuticals, inc's specialties? +

Pharmaceuticals,biotechnology,and transplant

What is Veloxis pharmaceuticals, inc's industry? +

Veloxis pharmaceuticals, inc operates in the Biotechnology research industry.

What is Veloxis pharmaceuticals, inc's revenue? +

Veloxis pharmaceuticals, inc's revenue is 11m - 100m

What is Veloxis pharmaceuticals, inc's company size? +

Veloxis pharmaceuticals, inc has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.